MALAT1 rs619586 A/G polymorphisms are associated with decreased risk of lung cancerMing Chen, Liming Fan, Deng Cai et al.|Medicine|2021Cited by 13
Inotuzumab ozogamicin then blinatumomab for older adults with newly diagnosed, ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Extended follow-up of alliance for clinical trials in oncology A041703 cohort 1 reveals durable remission and survivalMatthew J. Wieduwilt, Richard M. Stone, Wendy Stock et al.|Blood|2025Cited by 2